BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 26
• 27
• 28
• 29
• 30

• Business

  CorMedix: Final Closing of 2012 Financing

  November 15, 2012

   · 

  1 min read
• Pharm Country

  Vasomedical Inc. Named on Deloitte & Touche LLP (New York, New York)'s 2012 Technology Fast 500 List

  November 15, 2012

   · 

  3 min read
• Pharm Country

  Rosetta Genomics Ltd. Added to Ocean Tomo 300 Patent Index

  November 15, 2012

   · 

  4 min read
• Vertex Pharmaceuticals Incorporated Release: INCIVEK™ (telaprevir) Now Funded in Alberta and New Brunswick for People With Hepatitis C

  November 15, 2012

   · 

  1 min read
• Business

  Interleukin Genetics Inc. Reports Third Quarter 2012 Financial Results

  November 15, 2012

   · 

  1 min read
• Drug Development

  Del Mar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting

  November 15, 2012

   · 

  6 min read
• Business

  Targacept, Inc. Appoints Stephen A. Hill, M.D., President and CEO

  November 15, 2012

   · 

  6 min read
• Biotech Bay

  Intarcia Therapeutics, Inc. Secures $210 Million Financing to Fund Its Global Phase 3 Program

  November 15, 2012

   · 

  5 min read
• Business

  Johnson & Johnson, Eli Lilly and Company, Merck & Co., Inc. Team Up to Form Clinical Trial Site Database

  November 15, 2012

   · 

  5 min read
• Drug Development

  Threshold Pharmaceuticals, Inc. Reports Updated Phase 2 Results Including Analysis of Maintenance Therapy With TH-302 Following Induction Therapy With TH-302 Plus Doxorubicin in Soft Tissue Sarcoma

  November 15, 2012

   · 

  7 min read